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ABSTRACT 
 
In silico identification and characterization of vaccine antigens has opened up new frontiers in the 
field of reverse vaccinology to mitigate the effects of livestock diseases by development of new 
subunit vaccines. This study aims to characterize, express and purify MSC_0265 for eventual use in 
immunoassays and inoculation in goats. Mycoplasma mycoides subs. mycoides (Mmm) and 
Mycoplasma capricolum capripneumoniae (Mccp) are similar pathogens on the genomic level and 
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are the causative agents of Contagious Bovine Pleuropneumonia (CBPP) in cattle and Contagious 
Caprine Pleuropneumonia (CCPP) in goats respectively. In this study, BLAST was used to identify 
the homology of MSC_0265 in Mycoplasma capricolum capripneumoniae genome and the protein it 
is similar to. Characterization of MSC_0265 was also done using I-TASSER to predict secondary 
structure, solvent accessibility, normalised B-factor, 3D models and function. With cut off points of 
0.0 for E-value, 100% for Query coverage and 90% for Identity, MSC_0265 a pyruvate 
dehydrogenase enzyme gave a high homology score on tBLASTn and BLASTp. It had earlier been 
cloned in pGS21a vector before proceeding with expression and purification of the His-tagged 
protein by Ni-NTA affinity chromatography. This study identified the homologue of MSC_0265 as 
protein WP_029333261.1 in the Mycoplasma capricolum capripneumoniae genome (Accession 
NZ_LN515398.1) using tBLASTn and BLASTp. Additionally, MSC_0265 was characterized and its 
optimal expression profile and estimated molecular weight verified.  
 
 
Keywords: Mmm; CBPP; Mccp; CCPP; BLAST; I-TASSER; expression; purification. 
 
1. INTRODUCTION 
 
Mycoplasma mycoides subsp. mycoides (Mmm), 
previously specified as Mmm Small Colony [1] 
and Mycoplasma capricolum subsp. 
capripneumoniae (Mccp), are two members of 
Mycoplasma ‘mycoides cluster’, and are 
responsible for Contagious Bovine 
Pleuropneumonia (CBPP) in cattle and 
Contagious Caprine Pleuropneumonia (CCPP) in 
goats respectively. Both diseases cause 
significant losses in livestock, particularly in 
Africa and parts of Asia, besides being threats to 
disease-free countries [2]. 
 
Studies have shown that species of the 
Mycoplasma ‘mycoides cluster’ can survive in 
non-primary hosts with bovine pathogens Mmm 
and M. leachii having been isolated from goats 
[3], and caprine pathogens, Mycoplasma 
capricolum subsp. capripneumoniae (Mccp) and 
Mycoplasma mycoides subsp. capri (Mmc) being 
isolated from cattle [4]. Isolation of different 
Mycoplasma ‘mycoides cluster’ members from a 
single diseased animal has also been reported 
[5], which has brought forth the idea of 
development of different variants arising from 
exchange of pathogen genetic material among 
animals kept together like in the case of 
pastoralism in most parts of Africa [6]. 
 
CBPP and CCPP are respiratory illness 
characterized by the presence of sero-fibrinous, 
interstitial pneumonia, interlobular oedema and 
hepatization giving a marbled appearance of the 
lung and capsulated lesions termed sequestra in 
the lungs of affected cattle and goats 
respectively. The occurrence of subacute, 
asymptomatic infections and chronic carriers 
after the clinical phase of the disease are 
generally believed to create major problems in 
the control of this disease. CBPP is present in 
the Middle East, Asia, and is now considered the 
most significant bacterial disease of cattle in 
Africa. The last reported occurrence of CBPP in 
Europe was in Portugal in 1999. CCPP causes 
high mortality rates of up to 80% [7]. 
 
Vaccines play a key role in the control and 
prevention of infectious diseases. Pasteur's 
procedure, to ‘isolate, inactivate, and inject’ the 
disease-causing agent, has played a key role in 
production of inactivated and live attenuated 
vaccines throughout the 20th century [8]. 
Sequencing of the first bacterial genome, 
Haemophilus influenzae in 1995, and the arrival 
of the era of microbial genomics has led to many 
advances in vaccinology. The advent of genome 
sequencing technologies and use of 
bioinformatics tools has enabled researchers to 
explore the genomes of microorganism for 
purposes of antigen discovery and vaccine 
development.  
 
The first protein based non-recombinant vaccine 
was a highly active vaccine to hepatitis B 
consisting of purified hepatitis B surface antigen 
(HBsAg) from human plasma [9]. The first 
vaccine to be produced using recombinant DNA 
technology was licensed in 1986 after the 
successful expression of HBsAg in yeast [10]. 
This new vaccine efficiently elicited protective 
antibodies after vaccination of chimpanzees [11], 
thereby replacing the plasma derived hepatitis B 
vaccine in human use. 
 
The current CBPP and CCPP vaccines are live 
attenuated and which have a number of shortfalls 
hence necessitating the need for research and 
development of better vaccines. The new 
approach, currently known as Reverse 
vaccinology [12], was first described in 2000 to 
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identify the novel meningococcal vaccine 
candidates from the genome sequence of a 
Neisseria meningitidis serogroup B strain. It 
involves the in silico analysis of the whole 
genome of the pathogen to identify genes that 
encode proteins with potential as vaccine 
candidates. A general starting point is the 
prediction of surface or intracellular proteins. 
These selected surface proteins are then 
expressed in E. coli or other expression vehicles 
and used to perform immunoassays and animal 
field challenge to analyse immune responses. 
However, the applications of reverse vaccinology 
projects have surpassed just the analysis of a 
single meningococcal genome [13]. Potential 
advantages this technique has over the current 
live attenuated vaccines include, being safer, 
have better efficacy, longer shelf life and are 
thermostable. Subunit vaccine candidates 
typically consist of surface proteins or 
polysaccharides [14]. 
 
Advanced sequencing technologies and high 
throughput proteomics have evolved to include 
the analysis of several genomes within a species 
like pan-genomic analysis of group B 
streptococcus (GBS) [15]. Additionally, closely 
related species for examples comparative 
genomic analysis of GBS, group A streptococcus 
(GAS) and Streptococcus pneumoniae as well as 
between pathogenic and commensal members of 
the same species like comparative genomics of 
E. coli have been analysed [16,17]. 
 
In silico identification of Mmm protein antigens 
from the complete genome sequence of PG1 [18] 
and Gladysdale [19] were done at VIDO – 
InterVac and a reverse vaccinology approach 
used to determine protein antigen localization, 
adhesion probability and finally vaccine 
candidate prediction of the proteins using Vaxign 
[20]. In total, 58 Mmm proteins were identified. 
Additionally, eight predicted Mmm surface 
proteins that had earlier been described 
elsewhere were also included [21,22], making a 
sum total of 66 proteins. These proteins were 
used to inoculate cattle and their immune 
responses analyzed after challenge. 13 proteins 
gave the best titres [23]. 
 
Other innovative and important vaccine research 
fields have come up, such as 
immunoproteomics, structural biology and 
systems biology. These have become 
instrumental in vaccine development and in 
aiding researchers in overcoming the limits of 
conventional approaches in the discovery and 
development of novel vaccines especially for 
microorganisms whose culture has proven a 
challenge [24,25,26]. 
 
2. MATERIALS AND METHODS 
 
2.1 Download and Analysis of Protein 
Sequences 
 
Sequences of the 13 potential Mmm proteins 
were downloaded from NCBI 
(www.ncbi.nlm.nih.gov/) [27] on the protein 
database drop down tab and saved in FASTA 
format. Kyoto Encyclopedia of Genes and 
Genomes (KEGG) database was used to verify 
the protein sequences. KEGG was accessed on 
www.genome.jp/kegg [28]. Analysis of the 
predicted PDB protein structure of MSC_0265 
was done by I-TASSER as explained on 2.4. 
 
2.2 Homology Based Analysis of Mmm 
(PG1) Proteins to Mccp (F38) Proteins 
Using BLAST in the Nucleotide 
Collection and Non-redundant 
Databases 
 
tBLASTn portal was used to search for translated 
nucleotide databases using a protein query 
which in this case involved the analysis of 
homology of the 13 Mmm proteins with the Mccp 
genome (Accession number NZ_LN515398.1) 
with cut off points set at 0.0 for e-value, 100%     
for query coverage and 90% for Identity.         
This portal was accessed through; 
www.blast.ncbi.nlm.nih.gov/Blast.cgi on the 
Nucleotide collection (nr/nt) database. 
 
BLASTp is a program used to search other 
protein databases using a protein query. It was 
used to search for homologues proteins in the 
Mccp (F38 strain) genome. It was accessed 
through; www.blast.ncbi.nlm.nih.gov/Blast.cgi on 
the Non-redundant protein sequence (nr) 
database [29]. 
 
2.3 Pairwise Alignment of MSC_0265 and 
WP_029333261.1 Using EMBOSS 
Needle 
 
The Mmm protein MSC_0265 was aligned to its 
Mccp homologue WP_029333261.1 using 
EMBOSS Needle accessed on; 
www.ebi.ac.uk/Tools/psa/emboss_needle/. 
EMBOSS Needle is a pairwise alignment 
program that creates an optimal global alignment 
of two sequences using the Needleman-Wunsch 
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algorithm. Identity is the percentage of identical 
matches between the two sequences over the 
reported aligned region (including any gaps in 
the length). Similarity is the percentage of 
matches between the two sequences over the 
reported aligned region (including any gaps in 
the length) [30]. 
 
2.4 I-TASSER Analysis of MSC_0265 
 
I-TASSER (Iterative Threading ASSEmbly 
Refinement) is a hierarchical approach to protein 
structure and function prediction. Structural 
templates are first identified from the PDB by 
multiple threading approach LOMETS. For each 
target, I-TASSER simulations generate a large 
ensemble of structural conformations, called 
decoys. To select the final models, I-TASSER 
uses the SPICKER program to cluster all the 
decoys based on the pair-wise structure 
similarity, and reports up to five models which 
corresponds to the five largest structure clusters. 
The confidence of each model is quantitatively 
measured by C-score that is calculated based on 
the significance of threading template alignments 
and the convergence parameters of the structure 
assembly simulations. C-score is typically in the 
range of [5,2], where a C-score of a higher value 
signifies a model with a higher confidence and 
vice-versa. TM-score and RMSD are estimated 
based on C-score and protein length following 
the correlation observed between these qualities. 
Since the top 5 models are ranked by the cluster 
size, it is possible that the lower-rank models 
have a higher C-score in rare cases. Although 
the first model has a better quality in most cases, 
it is also possible that the lower-rank models 
have a better quality than the higher-rank models 
as seen on benchmark tests. If the I-TASSER 
simulations converge, it is possible to have less 
than 5 clusters generated; this is usually an 
indication that the models have a good quality 
because of the converged simulations [31,32,33]. 
 
This server was accessed through 
http://zhanglab.ccmb.med.umich.edu/I-TASSER 
for prediction of secondary structure. The 
secondary structure is predicted based on 
sequence information from the PSSpred 
algorithm [33], which works by combing seven 
neural network predictors from different 
parameters and PSI-BLAST [29]. 
 
Solvent accessibility and normalized B-factor, (B-
factor is a value to indicate the extent of the 
inherent thermal mobility of residues/atoms in 
proteins). In I-TASSER, this value is deduced 
from threading template proteins from the PDB in 
combination with the sequence profiles derived 
from sequence databases. The reported B-factor 
profile in the figure below corresponds to the 
normalized B-factor of the target protein, defined 
by B=(B'-u)/s, where B' is the raw B-factor value, 
u and s are respectively the mean and standard 
deviation of the raw B-factors along the 
sequence [31,32,33]. 
 
After the structure assembly simulation, I-
TASSER uses the TM-align structural alignment 
program to match the first I-TASSER model to all 
structures in the PDB library. This section reports 
the top 10 proteins from the PDB that have the 
closest structural similarity, i.e. the highest TM-
score, to the predicted I-TASSER model. Due to 
the structural similarity, these proteins often have 
similar function to the target.PDB files for 
analysis were selected based on best hits. 
 
2.5 Expression and Purification of 
MSC_0265 
 
The Qiagen Expressionist and Purification 
manual (Protocol 7) was used for expression. 
 
BL21 STAR E. coli strain containing the histidine 
tagged protein was grown overnight in 5 ml of 
phytone media with 5µl of Ampicillin (100 mg/ml), 
(Sigma) then transferred to 2 litre conical flasks 
containing 1 litre phytone media (BD 
Biosciences) the following day containing 1ml of 
Ampicilline (100 mg/ml). The shaker–incubator 
used was Innova 4430 set at 37ºC at 221 RPM. 
Induction with IPTG 1 mM (Thermo Scientific) 
was done after attainment of 0.25 ODs using the 
Ultrospec 3100 pro spectrophotometer and 2 ml 
samples taken at 0 hrs (before induction), 2 hrs, 
4 hrs, 6 hrs, and 16 hrs (Overnight) after 
induction. 
 
For purification, Protocol 17 on the Qiagen 
QIAexpressionist™ manual was used.Purification 
process was done after lysis of the overnight 
culture with 8M urea lysis buffer and 
centrifugation. Cleared lysate from 1litre culture, 
Ni-NTA resin, Empty columns and buffers (lysis, 
wash and elution) were of interest in this 
process. 50% Ni-NTA Agarose was added to 
lysate in the ratio of 1:4 and mixed gently by 
shaking (200 rpm on a rotary shaker) for 15–60 
minutes at room temperature. The capacity of 
each of the columns was about 12 ml and were 
soaked in distilled water before use. For each 
sample, a 50 ml corning tubes was used for the 
Cell lysate, Flow Through, Wash 1, Wash 2 and 
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Wash 3. 15 ml corning tubes were also prepared 
for Elution 1 and Elution 2. The lysate were then 
loaded – resin mixture carefully into an empty 
column. The first, second and third wash were 
done using 8 ml of Buffer C and contents 
collected in the 50 ml Wash 1, 2 and 3 tubes 
respectively. Elution 1 and 2 were done using 4 
ml of Buffer D and E respectively and contents 
collected in corresponding 15 ml Corning tubes. 
 
10% separating and 4% stacking gels were then 
prepared for SDS-PAGE analysis. Staining was 
done using PageBlue protein staining solution 
(Thermo Fisher Scientific). The marker of choice 
was the 10-170 kDa PageRuler™ prestained 
protein ladder (Thermo Scientific). 
 
2.6 Quantification of MSC_0265 
 
Quantification was done using the BIORAD DC 
Protein assay consisting of Reagent A (alkaline 
copper tartrate solution), Reagent B (dilute Folin 
reagent) and reagent S. A standard 96 well plate 
together with 8 standard tubes (0.1, 0.2, 0.4, 0.6, 
0.8, 1.0, 1.2, 1.4 mg/ml) were used. Qiagen 
Buffer D was used as blank. 
 
5 µl of standards and samples were pipetted into 
a clean dry microtiter plate, 25 µl of reagent A 
added into each well followed by addition of     
200 µl of reagent B then plate gently agitated 
and absorbance (750 nm) read after 15 minutes. 
 
3. RESULTS AND DISCUSSION 
 
3.1 Homology Based Analysis of Mmm 
(PG1) Proteins to Mccp (F38) Proteins 
Using BLAST in the Nucleotide 
Collection and Non-redundant 
Databases 
 
3.1.1 tBLASTn analysis 
 
When the 13 Mmm protein sequences were 
subjected to a tBLASTn analysis with cut off 
parameters set as 0.0 for e-value, 100% for 
query coverage and 90% for Identity, the proteins 
MSC_0160 and MSC_0265 gave the best 
homology scores against the Mccp (F38 strain) 
genome (Table 1). 
 
MSC_0160 had an E-value of 0.0, Query 
coverage of 100% and Identity of 99% while 
MSC_0265 had an E-value of 0.0, Query 
coverage of 100% and Identity of 90% (Table 1). 
With scoring parameters of BLOSUM62 as the 
matrix, Gap costs existence as 11 and Extension 
as 1 with a conditional compositional score 
matrix adjustment, an inference can be made 
that there is shared ancestry between Mmm and 
Mccp genomes shown by the high homology 
scores of the Mmm proteins in the Mccp 
genome. 
 
3.1.2 BLASTp analysis 
 
When MSC_0160 and MSC_0265 protein 
sequences were subjected to the BLASTp portal 
on the algorithm of BLASTp (protein-protein 
BLAST), WP_011166362.1 and 
WP_029333261.1 were identified as the 
respective homologues in Mccp (F38 strain), 
(Table 2). MSC_0160 was shown to have an E-
value of 0.0, Query coverage of 100% and 
Identity of 100% to the Mccp protein 
WP_011166362.1. The protein of interest for this 
study, MSC_0265 was shown to have an E-value 
of 0.0, Query coverage of 100% and Identity of 
99% to the Mccp protein WP_029333261.1 with 
similar functions and protein lengths (Table 2). 
This therefore infers presence of conserved gene 
encoding proteins with similar functions and 
common ancestry among the two members of 
the Mycoplasma ‘mycoides cluster’. 
 
3.2 Pairwise Alignment of MSC_0265 and 
WP_029333261.1 Sequences Using 
EMBOSS Needle Program 
 
The pairwise alignment of MSC_0265 (Accession 
number NP_975264.1) and WP_029333261.1 on 
the EMBOSS Needle platform generated an 
Identity of 368/370 (99.5%), similarity of 369/370 
(99.7%) with 0 gaps and gap penalty of 10 on the 
EBLOSUM62 matrix parameter. Mismatches 
were at positions 38 and 100 only (Fig. 1). The 
high degree of similarity and identity therefore 
leads to prediction of similar characteristics, 
features and metabolic functions within the 
respective genomes. 
 
3.3 I-TASSER Analysis of MSC_0265 
 
3.3.1 Secondary structure prediction of 
MSC_0265 by I-TASSER 
 
The sequence of MSC_0265 was submitted to 
the I-TASSER suite and the predicted secondary 
structure suggests that this protein is an alpha-
beta protein, which contains 16 alpha-helices (in 
red) and 7 beta-strands (in blue). “H,” “S,” and 
“C” indicate helix, strand, and coil, respectively 
(Fig. 2). Secondary structure prediction is 
important in the study of protein structure 
classification and function. 
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Table 1. tBLASTn homology results of the 13 Mmm (PG1 strain) against the Mccp (F38 strain) 
genome 
 
Protein Function E-value Query 
coverage (%) 
Identity 
(%) 
Protein 
length (AA) 
MSC_0136 Hypothetical protein 6e-88 85 59 322 
MSC_0957 Prolipoprotein 2e-151 96 63 433 
MSC_0499 Prolipoprotein 0.0 100 70 717 
MSC_0431 Prolipoprotein 4e-12 37 46 356 
MSC_0776 Prolipoprotein 3e-135 77 56 782 
MSC_0816 Hypothetical protein 1e-73 75 61 405 
MSC_0160 Elongation factor Tu 0.0 100 99 395 
MSC_0775 Prolipoprotein 0.0 100 63 727 
MSC_0013 Prolipoprotein 4e-56 76 39 548 
MSC_0610 Molecular chaperone Dnak 0.0 94 96 591 
MSC_0265 Pyruvate dehydrogenase E1 0.0 100 90 370 
MSC_0052 Hypothetical protein 0.0 100 67 691 
MSC_0240 Prolipoprotein 1e-149 100 49 554 
 
 
 
Fig. 1. Pairwise alignment of MSC_0265 and WP_029333261.1 sequences using EMBOSS 
Needle program 
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3.3.2 Prediction of solvent accessibility 
 
The predicted solvent accessibility is presented 
in 10 levels, from buried (0) to highly exposed (9) 
and is predicted by the SOLVE program (Y. 
Zhang, unpublished). Most surface parts of this 
protein are buried (Fig. 3) and are therefore 
minimally accessible to solvents. 
 
3.3.3 Prediction of normalised B-factor  
 
The regions at the N- and C- terminals and most 
of the loop regions are predicted with positive 
normalized B-factors, indicating that these 
regions are structurally more flexible than other 
regions. On the other hand, the predicted 
normalized B-factors for the alpha and beta 
regions are negative or close to zero, suggesting 
these regions are structurally more stable as 
shown in Fig. 4. 
 
B-factor is a value to indicate the extent of the 
inherent thermal mobility of residues/atoms in 
proteins. In I-TASSER, this value is deduced 
from threading template proteins from the PDB in 
combination with the sequence profiles derived 
from sequence databases. 
 
3.3.4 Predicted 3 dimensional models of 
MSC_0265 
 
By having the highest C-score of 1.79, Fig. 5 
(Model 1) was predicted to be closest to the 
target protein followed by Fig. 6 (Model 2) with a 
C-score of -2.99 then finally, Fig. 7 (Model 3) with 
a C-score of 0.28. 
 
3.3.5 Predicted function using COACH 
 
COACH is based on the I-TASSER structure 
prediction. COACH is a meta-server approach 
that combines multiple function annotation 
results from the COFACTOR, TM-SITE and S-
SITE programs. 
 
3.3.5.1 Ligand binding sites 
 
The highest ranked hit below generated a C-
score of 0.87, cluster size of 153 denoting 
number of templates in the cluster with predicted 
ligand name of TDP. There were 17 ligand 
binding site residues as shown in Table 3. 
 
Table 2. Homologues of MSC_0160 and MSC_0265 in Mccp (F38) genome 
 
Protein Function E-value Query 
coverage 
(%) 
Identity 
(%) 
Homologue 
accession 
number 
Protein 
length 
(AA) 
MSC_0160 Elongation factor Tu 0.0 100 100 WP_011166362.1 395 
MSC_0265 Pyruvate dehydrogenase E1 0.0 100 99 WP_029333261.1 370 
 
 
 
Fig. 2. Sequence and secondary structure prediction of MSC_0265 
  
 
 
Orwe et al.; IJBCRR, 17(3): 1-12, 2017; Article no.IJBCRR.34125 
 
 
 
8 
 
 
 
Fig. 3. Predicted solvent accessibility 
 
 
 
Fig. 4. Predicted normalised B-factor 
 
 
 
 
 
 
 
 
 
Table 3. The predicted ligand binding site residues of highest ranked PDB hit 
 
Rank C-score Cluster size PDB hit Ligand name Ligand binding site residues 
1 0.87 153 1olxA TDP 94, 95, 96, 135, 136, 137, 165, 
166, 167, 168, 171, 193, 195, 197, 
198, 199, 264 
 
Predicted binding ligands are shown by green 
yellow sphere and binding residues by blue ball 
and stick. 
 
3.3.6 Enzyme commission numbers (EC) and 
active sites 
 
The highest ranked PDB hit 1qs0A was 
generated with a confidence C-scoreEC of 0.734. 
TM-score which is the measure of the structural 
similarity between query and template protein 
was 0.873. RMSDα is the root mean square 
division between residues that are structurally 
aligned by TM-align. The Identityα which was 
0.293 is the percentage sequence identity in the 
structurally aligned region. The Enzyme 
commission number was 1.2.4.4 and active site 
residue being 264 (Table 4). 
Fig. 5. Model 1 
C-score=1.79 
Estimated TM-score = 
0.97±0.05 
Estimated RMSD 
=3.0±2.2Å 
 
Fig. 6. Model 2 
C-score=-2.99 
 
Fig. 7. Model 3 
C-score= 0.28 
 
  
 
 
Orwe et al.; IJBCRR, 17(3): 1-12, 2017; Article no.IJBCRR.34125 
 
 
 
9 
 
Table 4. Predicted enzyme commission numbers (EC) and active site of highest PDB hit 
 
Rank C-scoreEC PDB 
hit 
TM-score RMSDα 
 
Identityα 
 
Coverage EC 
number 
Active site 
residue 
1 0.734 1qs0A 0.873 2.07 0.293 0.932 1.2.4.4 264 
 
 
 
Fig. 8. Model of the highest rank predicted 
ligand binding sites 
 
Predicted Enzyme commission active site 
residues are shown by coloured ball and stick in 
Fig. 9. 
 
 
 
Fig. 9. Predicted active site residue of the 
highest rank model 
 
3.4 Expression and Purification of 
Recombinant MSC_0265 
 
3.4.1 Expression of MSC_0265 
 
Fig. 10 shows the expression profile of the 
histidine tagged recombinant protein MSC_0265 
on SDS-PAGE of 10% separating gel and 4% 
stacking gel stained using page blue. There is no 
leaky expression at 0 hours and thereafter the 
expression of the protein is consistent over the 
hours shown. Aliquots of expressed protein at 
each time zone were loaded on the gel as 
shown. Phytone media therefore effectively 
supported the growth of the BL21 STAR (DE3) E. 
coli containing the insert. Its use as a cell factory 
is well established and studied thereby making it 
the most popular expression platform. The 
estimated molecular weight was confirmed by 
visualization to be 74kDa. 
 
 
 
Fig. 10. Expression profile of MSC_0265 
M: Marker, 1: 0 hrs, 2: 2 hrs, 3: 4 hrs, 4: 6hrs, 5: 16hrs 
 
3.4.2 Purification of MSC_0265 
 
After expression and lysis of the E. coli, an 
aliquot of the overnight culture was subjected to 
a purification process. Non specific proteins are 
washed off through the column containing Nickel-
NTA Agarose resin during  first wash cycles with 
buffers at higher PH. The histidine tagged protein 
that attaches to the resin are then eventually 
eluted at PH 4.5. Efficiency of the process  is 
determined by presence of minimal background 
on the gel as shown in Fig. 11. 
 
 
 
Fig. 11. Purification profile of MSC_0265 
M: Marker, 1: Cell lysate, 2: Flow through, 3: Wash 1 
(PH 6.3), 4: Wash 2 (PH 6.3), 5: Elution 1a (PH 4.5), 
6: Elution 1b (PH 4.5)
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Table 5. Quantification by use of Bio Rad Detergent Compatible™ protein assay 
 
Protein Concentration (mg/ml) Volume Yield/ 1L culture (mg) Total yield (mg) 
His-MSC 0265 E1 0.104 12 1.248 2.748 
His-MSC 0265 E1 0.125 12 1.5 - 
 
3.4.3 Quantification of MSC_0265 
 
Protein quantification is important in the analysis 
of proteins expression potential especially if a 
protein would eventually be produced in an 
industrial setup. It also sheds light on proteins 
that might need optimization of expression and 
purification conditions or determination of 
generally poor expressers. From the yield of a 1 
litre culture of MSC_0265, 2.748mg of protein 
was generated (Table 5), which is considered as 
normal and therefore this infers that this protein’s 
production can be scaled up. 
 
4. CONCLUSION 
 
MSC_0265, is a pyruvate dehydrogenase E1 
protein and first component enzyme of the 
pyruvate dehydrogenase complex (PDC). The 
pyruvate dehydrogenase complex facilitates the 
transformation of pyruvate into acetyl-CoA in a 
process called pyruvate decarboxylation. Acetyl-
CoA may then be used in the citric acid cycle to 
carry out cellular respiration, therefore pyruvate 
dehydrogenase contributes to linking the 
glycolysis metabolic pathway to the citric acid 
cycle and releasing energy through Nicotinamide 
adenine dinucleotide (NADH). 
 
MSC_0256 was identified as a potential high 
score Mmm immunogenic homologue in the 
Mccp (F38 strain Accession NZ_LN515398.1) 
genomeas protein WP_029333261. The 
homologue in Mccp was found to have similar 
sequence length and function. It 
wascharacterized and found to have a secondary 
structure that is alpha-beta in nature with mostly 
buried solvent accessibility regions. The 
Histidine-tagged protein, was successfully 
expressed and purified clearing the way for 
performing immunoassays, upscale and eventual 
challenge of goats. 
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